FDA probing deaths with DMD gene therapy Elevidys
The FDA has launched a formal investigation into two reports of fatal acute liver failure in patients treated with Sarepta and Roche's Duchenne muscular dystrophy (DMD) gene therapy Elevidys. The two deaths – one reported in March and the second …